Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,intangibleAssets,capitalSurplus,totalLiab,totalStockholderEquity,otherCurrentLiab,totalAssets,commonStock,retainedEarnings,otherLiab,treasuryStock,cash,totalCurrentLiabilities,otherStockholderEquity,propertyPlantEquipment,totalCurrentAssets,netReceivables,inventory,accountsPayable,changeToLiabilities,totalCashflowsFromInvestingActivities,netBorrowings,totalCashFromFinancingActivities,changeToOperatingActivities,changeInCash,totalCashFromOperatingActivities,changeToInventory,changeToAccountReceivables,changeToNetincome,WC,language,region,quoteType,triggerable,quoteSourceName,currency,regularMarketChangePercent,regularMarketDayRange,regularMarketPreviousClose,bid,ask,bidSize,askSize,messageBoardId,fullExchangeName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,epsTrailingTwelveMonths,gmtOffSetMilliseconds,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,priceHint,shortName,longName,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,marketState,exchange,market,twoHundredDayAverageChangePercent,marketCap,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,esgPopulated,tradeable,exchangeDataDelayedBy,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,Shares Short 4,Short Ratio 4,Short % of Float 4,Short % of Shares Outstanding 4,Shares Short (prior month ) 4,Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,fullTimeEmployees,longBusinessSummary,city,phone,state,compensationAsOfEpochDate,country,website,maxAge,address1,fax,industry,address2
t0,DECN,-2895839,199792992,,,-972232,,-972232,562099,108083,-454016,-454016,,-57000,,,,0,537799,991815,429716,-518216,,-972232,-972232,3229655,79946485,5135258,333816,240000,5469831,356431,-79565505,245069,-403595,439179,4890189,-403595,802315,1437861,884210,114472,1564364,141574,-5000,430000,430000,2016,-83162,-508162,84937,59543,176000,-3452328,en-US,US,EQUITY,False,Delayed Quote,USD,7.692309,0.0065 - 0.015,0.011,0.0,0.0,0,0,finmb_2870137,Other OTC,USD,207978,241454,0.00694,115.66667,6.0E-5 - 0.3924,-0.3854,-0.98216105,6e-05,0.3924,-0.11,-14400000,0.001,0.007308333,-0.00030833296,-0.042189233,0.017597888,-0.010597887,4,DECISION DIAGNOSTICS CORP,Decision Diagnostics Corp.,0.007,1630439308,0.0005000001,0.015,0.015,0.0065,39500,REGULAR,PNK,us_market,-0.60222495,1398551,7.0,15,America/New_York,EDT,False,False,0,-2.17,,,0.3924,0.0001,0.0073,0.0176,207.98k,241.45k,199.79M,,353.62M,0.00%,0.20%,,,,,,,,,,,0.00%,,,1:1,"Dec 27, 2011","Dec 30, 2020","Mar 30, 2021",0.00%,-116.44%,-24.09%,"-16,700.34%",1.94M,0.01,-6.30%,194.17k,,-29.87M,-0.1100,,439.18k,0,3.03M,905.28,0.29,0.00,-1.56M,-1.56M,Value,91361,Healthcare,6,"Decision Diagnostics Corp. develops smart phone based electronic medical record (EMR) technologies. The company offers prescription and non-prescription diagnostics; home testing products for the chronically ill; fulfillment services to direct to patient diabetes programs; and cell phone centric e-health products and technologies development services. It manufactures and distributes GenUltimate! glucose test strips, a Class II medical device for at-home use for the measurement of glucose; PetSure! glucose test strip for the glucose testing of dogs and cats designed to work with the Zoetis AlphaTrak and AlphaTrak II glucometers, a legacy meter; GenUltimate! 4Pets Glucose system, a proprietary glucose measuring system, including GenUltimate! 4Pets test strip and Avantage meter, for the testing of dogs, cats, and horses; and GenUltimate! Sure and GenUltimate! Precis test strips. In addition, it engages in the acquisition and holding of intellectual property including patents and trademarks and specialty manufacturing equipment. Further, the company also provides MD@Hand, an inpatient/outpatient management suite; Practice Probe, a data mining utility used to extract information from the physician's practice management system; and ResidenceWare, a residential management system that facilitates the relay of information from commercial and residential real estate management companies to occupying tenants using networking software systems and applications. Its EMR technologies are used by physicians at the point of care. The company was formerly known as InstaCare Corp. and changed its name to Decision Diagnostics Corp. in November 2011. Decision Diagnostics Corp. was founded in 2000 and is based in Westlake Village, California.",Westlake Village,805 446 1973,CA,1577750400,United States,http://www.decisiondiagnostics.co,86400,2660 Townsgate Road,805 446 1983,Pharmaceutical Retailers,Suite 300
t-1,DECN,-2741819,199792992,,,-6949109,,-6949910,1304588,104154,-1200434,-1200434,,-127646,,,,801,521805,1722239,417651,-5748675,,-6949910,-6949910,3224655,79929070,5170149,482836,240000,5653742,354496,-79398546,245069,-402184,522341,4925080,-402184,802315,1626772,943753,160678,1702967,-112305,125845,68475,68475,-605695,206842,12522,332104,1069943,6278385,-3298308,en-US,US,EQUITY,False,Delayed Quote,USD,7.692309,0.0065 - 0.015,0.011,0.0,0.0,0,0,finmb_2870137,Other OTC,USD,207978,241454,0.00694,115.66667,6.0E-5 - 0.3924,-0.3854,-0.98216105,6e-05,0.3924,-0.11,-14400000,0.001,0.007308333,-0.00030833296,-0.042189233,0.017597888,-0.010597887,4,DECISION DIAGNOSTICS CORP,Decision Diagnostics Corp.,0.007,1630439308,0.0005000001,0.015,0.015,0.0065,39500,REGULAR,PNK,us_market,-0.60222495,1398551,7.0,15,America/New_York,EDT,False,False,0,-2.17,,,0.3924,0.0001,0.0073,0.0176,207.98k,241.45k,199.79M,,353.62M,0.00%,0.20%,,,,,,,,,,,0.00%,,,1:1,"Dec 27, 2011","Dec 30, 2020","Mar 30, 2021",0.00%,-116.44%,-24.09%,"-16,700.34%",1.94M,0.01,-6.30%,194.17k,,-29.87M,-0.1100,,439.18k,0,3.03M,905.28,0.29,0.00,-1.56M,-1.56M,Value,91361,Healthcare,6,"Decision Diagnostics Corp. develops smart phone based electronic medical record (EMR) technologies. The company offers prescription and non-prescription diagnostics; home testing products for the chronically ill; fulfillment services to direct to patient diabetes programs; and cell phone centric e-health products and technologies development services. It manufactures and distributes GenUltimate! glucose test strips, a Class II medical device for at-home use for the measurement of glucose; PetSure! glucose test strip for the glucose testing of dogs and cats designed to work with the Zoetis AlphaTrak and AlphaTrak II glucometers, a legacy meter; GenUltimate! 4Pets Glucose system, a proprietary glucose measuring system, including GenUltimate! 4Pets test strip and Avantage meter, for the testing of dogs, cats, and horses; and GenUltimate! Sure and GenUltimate! Precis test strips. In addition, it engages in the acquisition and holding of intellectual property including patents and trademarks and specialty manufacturing equipment. Further, the company also provides MD@Hand, an inpatient/outpatient management suite; Practice Probe, a data mining utility used to extract information from the physician's practice management system; and ResidenceWare, a residential management system that facilitates the relay of information from commercial and residential real estate management companies to occupying tenants using networking software systems and applications. Its EMR technologies are used by physicians at the point of care. The company was formerly known as InstaCare Corp. and changed its name to Decision Diagnostics Corp. in November 2011. Decision Diagnostics Corp. was founded in 2000 and is based in Westlake Village, California.",Westlake Village,805 446 1973,CA,1577750400,United States,http://www.decisiondiagnostics.co,86400,2660 Townsgate Road,805 446 1983,Pharmaceutical Retailers,Suite 300
t-2,DECN,-2989220,199792992,,,-4734379,,-4735220,442798,95977,-346821,-346821,,-127546,,,,841,520698,867519,424721,-4387558,,-4735220,-4735220,3243730,72787034,5788483,254510,240000,6043748,318296,-72448636,245070,-402184,615500,5543413,-402184,802315,1997703,1193697,188506,1649900,68373,-15250,519122,519122,134253,-34577,-538449,-17376,-248491,4260011,-3545710,en-US,US,EQUITY,False,Delayed Quote,USD,7.692309,0.0065 - 0.015,0.011,0.0,0.0,0,0,finmb_2870137,Other OTC,USD,207978,241454,0.00694,115.66667,6.0E-5 - 0.3924,-0.3854,-0.98216105,6e-05,0.3924,-0.11,-14400000,0.001,0.007308333,-0.00030833296,-0.042189233,0.017597888,-0.010597887,4,DECISION DIAGNOSTICS CORP,Decision Diagnostics Corp.,0.007,1630439308,0.0005000001,0.015,0.015,0.0065,39500,REGULAR,PNK,us_market,-0.60222495,1398551,7.0,15,America/New_York,EDT,False,False,0,-2.17,,,0.3924,0.0001,0.0073,0.0176,207.98k,241.45k,199.79M,,353.62M,0.00%,0.20%,,,,,,,,,,,0.00%,,,1:1,"Dec 27, 2011","Dec 30, 2020","Mar 30, 2021",0.00%,-116.44%,-24.09%,"-16,700.34%",1.94M,0.01,-6.30%,194.17k,,-29.87M,-0.1100,,439.18k,0,3.03M,905.28,0.29,0.00,-1.56M,-1.56M,Value,91361,Healthcare,6,"Decision Diagnostics Corp. develops smart phone based electronic medical record (EMR) technologies. The company offers prescription and non-prescription diagnostics; home testing products for the chronically ill; fulfillment services to direct to patient diabetes programs; and cell phone centric e-health products and technologies development services. It manufactures and distributes GenUltimate! glucose test strips, a Class II medical device for at-home use for the measurement of glucose; PetSure! glucose test strip for the glucose testing of dogs and cats designed to work with the Zoetis AlphaTrak and AlphaTrak II glucometers, a legacy meter; GenUltimate! 4Pets Glucose system, a proprietary glucose measuring system, including GenUltimate! 4Pets test strip and Avantage meter, for the testing of dogs, cats, and horses; and GenUltimate! Sure and GenUltimate! Precis test strips. In addition, it engages in the acquisition and holding of intellectual property including patents and trademarks and specialty manufacturing equipment. Further, the company also provides MD@Hand, an inpatient/outpatient management suite; Practice Probe, a data mining utility used to extract information from the physician's practice management system; and ResidenceWare, a residential management system that facilitates the relay of information from commercial and residential real estate management companies to occupying tenants using networking software systems and applications. Its EMR technologies are used by physicians at the point of care. The company was formerly known as InstaCare Corp. and changed its name to Decision Diagnostics Corp. in November 2011. Decision Diagnostics Corp. was founded in 2000 and is based in Westlake Village, California.",Westlake Village,805 446 1973,CA,1577750400,United States,http://www.decisiondiagnostics.co,86400,2660 Townsgate Road,805 446 1983,Pharmaceutical Retailers,Suite 300
t-3,DECN,-2767223,199792992,,,-17213945,,-17215031,507112,-204165,-711277,-711277,,-107102,,,,1086,362864,1074141,567029,-16502668,,-17215031,-17215031,3234690,68282653,5335694,467467,240000,5803916,300414,-67713417,245070,-402183,650077,5090624,-402183,802315,1766911,945205,171130,1646899,11709,-37000,225089,225089,106793,-335655,-523744,-275998,138942,16709841,-3323713,en-US,US,EQUITY,False,Delayed Quote,USD,7.692309,0.0065 - 0.015,0.011,0.0,0.0,0,0,finmb_2870137,Other OTC,USD,207978,241454,0.00694,115.66667,6.0E-5 - 0.3924,-0.3854,-0.98216105,6e-05,0.3924,-0.11,-14400000,0.001,0.007308333,-0.00030833296,-0.042189233,0.017597888,-0.010597887,4,DECISION DIAGNOSTICS CORP,Decision Diagnostics Corp.,0.007,1630439308,0.0005000001,0.015,0.015,0.0065,39500,REGULAR,PNK,us_market,-0.60222495,1398551,7.0,15,America/New_York,EDT,False,False,0,-2.17,,,0.3924,0.0001,0.0073,0.0176,207.98k,241.45k,199.79M,,353.62M,0.00%,0.20%,,,,,,,,,,,0.00%,,,1:1,"Dec 27, 2011","Dec 30, 2020","Mar 30, 2021",0.00%,-116.44%,-24.09%,"-16,700.34%",1.94M,0.01,-6.30%,194.17k,,-29.87M,-0.1100,,439.18k,0,3.03M,905.28,0.29,0.00,-1.56M,-1.56M,Value,91361,Healthcare,6,"Decision Diagnostics Corp. develops smart phone based electronic medical record (EMR) technologies. The company offers prescription and non-prescription diagnostics; home testing products for the chronically ill; fulfillment services to direct to patient diabetes programs; and cell phone centric e-health products and technologies development services. It manufactures and distributes GenUltimate! glucose test strips, a Class II medical device for at-home use for the measurement of glucose; PetSure! glucose test strip for the glucose testing of dogs and cats designed to work with the Zoetis AlphaTrak and AlphaTrak II glucometers, a legacy meter; GenUltimate! 4Pets Glucose system, a proprietary glucose measuring system, including GenUltimate! 4Pets test strip and Avantage meter, for the testing of dogs, cats, and horses; and GenUltimate! Sure and GenUltimate! Precis test strips. In addition, it engages in the acquisition and holding of intellectual property including patents and trademarks and specialty manufacturing equipment. Further, the company also provides MD@Hand, an inpatient/outpatient management suite; Practice Probe, a data mining utility used to extract information from the physician's practice management system; and ResidenceWare, a residential management system that facilitates the relay of information from commercial and residential real estate management companies to occupying tenants using networking software systems and applications. Its EMR technologies are used by physicians at the point of care. The company was formerly known as InstaCare Corp. and changed its name to Decision Diagnostics Corp. in November 2011. Decision Diagnostics Corp. was founded in 2000 and is based in Westlake Village, California.",Westlake Village,805 446 1973,CA,1577750400,United States,http://www.decisiondiagnostics.co,86400,2660 Townsgate Road,805 446 1983,Pharmaceutical Retailers,Suite 300
